New drugs in clinical stages
Drugs for Degenerative Diseases
Drug for Osteoarthritis
Drug for Animal Osteoarthritis
New drugs in discovery stages
Drug for Immuno-Oncology
Drug for Alzheimer’s Disease
Drug for Type I Diabetes
Animal anti-cancer drug
Bio big data platform
Contract development Services
Contract development services
Material Synthesis & Analysis Services
Konex market listing
Our company was listed on the Konex market th...
Ensoltek's company name has be...
Ensoltek's company name has been changed ...
국내 최고수준의 신약개발 기업_토...
국내 최고수준의 신약개발 기업_토러스 투자증권 ...
Ensol Bioscience develops new ...
Ensol Bioscience is developing a new drug, En...
Company : Ensol Biosciences Inc. | CEO : Hae-Jin Kim | Business Number : 314-81-39908
Headquarter : 51, Techno 10-ro, Yuseong-gu, Daejeon, 34036, Korea | TEL : +82-42-939-4500 | FAX : +82-42-939-4501
Copyright (c) 2015 Ensol Biosciences Inc. All Rights Reserved.